Classification of HER2-negative breast cancers by ERBB2 copy number alteration status reveals molecular differences associated with chromosome 17 gene aberrations

BACKGROUND: Recently, HER2-negative breast cancers have been reclassified by protein expression into ‘HER2-low’ and ‘HER2-zero’ subgroups, but the consideration of HER2-low breast cancer as a distinct biological subtype with differing prognoses remains controversial. By contrast, non-neutral ERBB2 c...

Descripción completa

Detalles Bibliográficos
Autores principales: Loh, Jui Wan, Lim, Abner Herbert, Chan, Jason Yongsheng, Yap, Yoon-Sim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619358/
https://www.ncbi.nlm.nih.gov/pubmed/37920257
http://dx.doi.org/10.1177/17588359231206259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619358/
https://www.ncbi.nlm.nih.gov/pubmed/37920257
http://dx.doi.org/10.1177/17588359231206259

Ejemplares similares